General Information of the Cell Line
Cell Line ID
CL000187
Cell Line Name
Calu-6
Synonyms
CaLu-6
CALU-6
Calu.6
Calu 6
Calu6
CALU6
CaLu-06
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0236
Tissue Information
Pleural effusion
Disease
Lung adenocarcinoma (NCIt: C3512)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT02585, Proteasome subunit beta type-5
Compound ID Compound Name Compound Formula
CP0004620
(R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butylboronic acid
   Show/Hide
C19H25BN4O4
 1
1
IC50 = 3.9 nM
   TI
   LI
   LO
   TS
CP0034167
[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid
   Show/Hide
C14H19BCl2N2O4
 1
1
IC50 = 9 nM
   TI
   LI
   LO
   TS
CP0112227
(2S)-N-[(2S)-1-[(2-chlorophenyl)methylamino]-1-oxo-3-pyridin-4-ylpropan-2-yl]-N'-(2,2-dimethylpropyl)-2-[[2-(1H-indol-3-yl)-2-oxoacetyl]amino]butanediamide
   Show/Hide
C34H37ClN6O5
 1
1
IC50 = 9.5 nM
   TI
   LI
   LO
   TS
CP0849436
(S)-2-(2-(1H-indol-3-yl)-2-oxoacetamido)-N1-((S)-1-(benzylamino)-1-oxo-4-phenylbutan-2-yl)-N4-neopentylsuccinamide
   Show/Hide
C36H41N5O5
 1
1
IC50 = 9.7 nM
   TI
   LI
   LO
   TS
CP0755326
(S)-2-(2-(1H-indol-3-yl)-2-oxoacetamido)-N1-((S)-1-(2-chlorobenzylamino)-1-oxo-4-phenylbutan-2-yl)-N4-neopentylsuccinamide
   Show/Hide
C36H40ClN5O5
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0923548
(S)-N1-((S)-1-(benzylamino)-1-oxo-4-phenylbutan-2-yl)-2-(4-(benzyloxy)benzamido)-N4-neopentylsuccinamide
   Show/Hide
C40H46N4O5
 1
1
IC50 = 11 nM
   TI
   LI
   LO
   TS
CP0864842
(S)-2-(4-(benzyloxy)benzamido)-N1-((S)-1-(2-chlorobenzylamino)-1-oxo-4-phenylbutan-2-yl)-N4-neopentylsuccinamide
   Show/Hide
C40H45ClN4O5
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0755327
(S)-N1-((S)-1-(2-chlorobenzylamino)-1-oxo-4-phenylbutan-2-yl)-2-(5-methylisoxazole-3-carboxamido)-N4-neopentylsuccinamide
   Show/Hide
C31H38ClN5O5
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0849438
(S)-N1-((S)-1-(benzylamino)-1-oxo-4-phenylbutan-2-yl)-N4-neopentyl-2-(3-phenylpropanamido)succinamide
   Show/Hide
C35H44N4O4
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0880261
(S)-N1-((S)-1-(2-chlorobenzylamino)-1-oxo-4-phenylbutan-2-yl)-N4-neopentyl-2-(3-phenylpropanamido)succinamide
   Show/Hide
C35H43ClN4O4
 1
1
IC50 = 18 nM
   TI
   LI
   LO
   TS
CP0849440
(S)-N1-((S)-1-(2-chlorobenzylamino)-1-oxo-3-(pyridin-3-yl)propan-2-yl)-N4-neopentyl-2-(3-phenylpropanamido)succinamide
   Show/Hide
C33H40ClN5O4
 1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0881290
(S)-N1-((S)-1-(benzylamino)-1-oxo-4-phenylbutan-2-yl)-2-(5-methylisoxazole-3-carboxamido)-N2-neopentylsuccinamide
   Show/Hide
C31H39N5O5
 1
1
IC50 = 25 nM
   TI
   LI
   LO
   TS
CP0849435
(S)-N1-((S)-1-(benzylamino)-1-oxo-4-phenylbutan-2-yl)-N4-neopentyl-2-(2-(piperidin-1-yl)acetamido)succinamide
   Show/Hide
C33H47N5O4
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0881288
(S)-2-((S)-2-(2-(1H-indol-3-yl)-2-oxoacetamido)-3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)propanamido)-N-(4-methylbenzyl)-4-phenylbutanamide
   Show/Hide
C37H40N6O5
 1
1
IC50 = 30 nM
   TI
   LI
   LO
   TS
CP0849434
(S)-N1-((S)-1-(2-chlorobenzylamino)-1-oxopropan-2-yl)-N4-neopentyl-2-(3-phenylpropanamido)succinamide
   Show/Hide
C28H37ClN4O4
 1
1
IC50 = 35 nM
   TI
   LI
   LO
   TS
CP0877531
(S)-N1-((S)-1-(benzylamino)-1-oxo-4-phenylbutan-2-yl)-2-(4-tert-butylbenzamido)-N4-neopentylsuccinamide
   Show/Hide
C37H48N4O4
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0647535
5-methyl-N-((S)-1-((S)-1-((S)-1-(4-methylbenzylamino)-1-oxo-4-phenylbutan-2-ylamino)-1-oxo-4-phenylbutan-2-ylamino)-1-oxo-4-phenylbutan-2-yl)pyrazine-2-carboxamide
   Show/Hide
C44H48N6O4
 1
1
IC50 = 53 nM
   TI
   LI
   LO
   TS
CP0867343
(S)-N1-((S)-1-(benzylamino)-1-oxo-4-phenylbutan-2-yl)-2-(2-(4-fluorophenyl)acetamido)-N4-neopentylsuccinamide
   Show/Hide
C34H41FN4O4
 1
1
IC50 = 73 nM
   TI
   LI
   LO
   TS
CP0849433
(S)-N1-((S)-1-(2-chlorobenzylamino)-1-oxo-4-phenylbutan-2-yl)-2-(2-(4-fluorophenyl)acetamido)-N4-neopentylsuccinamide
   Show/Hide
C34H40ClFN4O4
 1
1
IC50 = 85 nM
   TI
   LI
   LO
   TS
CP0856343
(S)-N1-((S)-1-(cyclopropylmethylamino)-1-oxo-4-phenylbutan-2-yl)-N4-neopentyl-2-(3-phenylpropanamido)succinamide
   Show/Hide
C32H44N4O4
 1
1
IC50 = 360 nM
   TI
   LI
   LO
   TS
CP0849437
(S)-N1-((S)-1-(benzylamino)-1-oxo-4-phenylbutan-2-yl)-N4-neopentyl-2-pivalamidosuccinamide
   Show/Hide
C31H44N4O4
 1
1
IC50 = 610 nM
   TI
   LI
   LO
   TS
CP0849441
(S)-N1-((S)-1-(2-chlorobenzylamino)-1-oxo-3-(pyridin-3-yl)propan-2-yl)-2-(5-methylisoxazole-3-carboxamido)-N4-neopentylsuccinamide
   Show/Hide
C29H35ClN6O5
 1
1
IC50 = 690 nM
   TI
   LI
   LO
   TS
CP0916454
(S)-N1-((S)-1-(2-chlorobenzylamino)-1-oxo-3-(pyridin-4-yl)propan-2-yl)-2-(5-methylisoxazole-3-carboxamido)-N4-neopentylsuccinamide
   Show/Hide
C29H35ClN6O5
 1
1
IC50 = 940 nM
   TI
   LI
   LO
   TS
CP0898590
(S)-2-acetamido-N1-((S)-1-(benzylamino)-1-oxo-4-phenylbutan-2-yl)-N4-neopentylsuccinamide
   Show/Hide
C28H38N4O4
 1
1
IC50 = 960 nM
   TI
   LI
   LO
   TS
CP0877532
(S)-N1-((S)-1-(2-chlorobenzylamino)-1-oxopropan-2-yl)-2-(5-methylisoxazole-3-carboxamido)-N4-neopentylsuccinamide
   Show/Hide
C24H32ClN5O5
 1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0849442
N-((S)-3-(3-tert-Butyl-1,2,4-oxadiazol-5-yl)-1-((S)-1-(4-methylbenzylamino)-1-oxo-4-phenylbutan-2-ylamino)-1-oxopropan-2-yl)-5-methylisoxazole-3-carboxamide
   Show/Hide
C32H38N6O5
 1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0014985
BIBF-1120
   Show/Hide
C31H33N5O4  1
1
EC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0017774
4-[[7-[2,6-bis(fluoranyl)phenyl]-9-chloranyl-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid
   Show/Hide
C25H15ClF2N4O2  1
1
IC50 = 220 nM
   TI
   LI
   LO
   TS
CP0117616
US10245267, Example 1
   Show/Hide
C23H21F3N4O2  1
1
EC50 = 5200 nM
   TI
   LI
   LO
   TS
CP0160473
2-(4-(2-(1H-pyrazol-3-ylamino)-1H-benzo[d]imidazol-1-yl)-6-methyl-1,3,5-triazin-2-ylamino)acetonitrile
   Show/Hide
C16H14N10  1
1
IC50 = 590 nM
   TI
   LI
   LO
   TS
CP0227790
4-(4-chlorophenyl)-6-(3-methoxypiperidin-1-yl)-N-[3-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]pyrimidin-2-amine
   Show/Hide
C29H37ClN6O2  1
1
GI50 = 4400 nM
   TI
   LI
   LO
   TS
CP0472275
N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide
   Show/Hide
C29H29N9O  1
1
GI50 = 1700 nM
   TI
   LI
   LO
   TS
CP0544270
N-(3-tert-butylphenyl)-4-methyl-3-(6-morpholin-4-ylpyrimidin-4-yl)benzamide
   Show/Hide
C26H30N4O2  1
1
EC50 = 6400 nM
   TI
   LI
   LO
   TS
CP0566040
US10245267, Example 390
   Show/Hide
C23H22F3N5O3  1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0664754
(Z)-3-({4-[(2-Dimethylamino-acetyl)-methyl-amino]-phenylamino}-phenyl-methylene)-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid Methyl Ester
   Show/Hide
C28H28N4O4  1
1
EC50 > 1000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Pleural effusion)
Cell Line Name Organism Disease
U-937 Homo sapiens (Human) Adult acute monocytic leukemia
SU-DHL-1 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
SR Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
MC116 Homo sapiens (Human) B-cell non-Hodgkin lymphoma
K-562 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/A02 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/Adr Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/R7 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/DOX Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
MDA-MB-231 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-415 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-468 Homo sapiens (Human) Breast adenocarcinoma
SK-BR-3 Homo sapiens (Human) Breast adenocarcinoma
AU565 Homo sapiens (Human) Breast adenocarcinoma
CAL-51 Homo sapiens (Human) Breast carcinoma
CAL-120 Homo sapiens (Human) Breast carcinoma
DG-75 Homo sapiens (Human) Burkitt lymphoma
SUP-T1 Homo sapiens (Human) Childhood T lymphoblastic lymphoma
Pfeiffer Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
WSU-DLCL2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
Karpas-422 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
DoHH2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
KATO III Homo sapiens (Human) Down syndrome
GIST-T1 Homo sapiens (Human) Gastrointestinal stromal tumor
GIST-5R Homo sapiens (Human) Gastrointestinal stromal tumor
MZ-CRC-1 Homo sapiens (Human) Hereditary thyroid gland medullary carcinoma
L-428 Homo sapiens (Human) Hodgkin lymphoma
KM-H2 Homo sapiens (Human) Hodgkin lymphoma
T-47D Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T-47 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 MX100 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/VP Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D:A18 Homo sapiens (Human) Invasive breast carcinoma of no special type
MVLN Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF/MX Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/Topo Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7aro Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M6 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-10 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7piGST Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-Y1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/ADM Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7:WS8 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-FLV1000 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-neo/Her2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 cl.24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/DX1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-LC3 Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D-KBluc Homo sapiens (Human) Invasive breast carcinoma of no special type
Calu-3 Homo sapiens (Human) Lung adenocarcinoma
HCC78 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3122 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3255 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2122 Homo sapiens (Human) Lung adenocarcinoma
COR-L105 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1437 Homo sapiens (Human) Lung adenocarcinoma
HCC4006 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1792 Homo sapiens (Human) Lung adenocarcinoma
DFCI032 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1355 Homo sapiens (Human) Lung adenocarcinoma
NCI-H460 Homo sapiens (Human) Lung large cell carcinoma
U-1810 Homo sapiens (Human) Lung large cell carcinoma
COR-L23/R Homo sapiens (Human) Lung large cell carcinoma
H460/MX20 Homo sapiens (Human) Lung large cell carcinoma
H460R Homo sapiens (Human) Lung large cell carcinoma
H69AR Homo sapiens (Human) Lung small cell carcinoma
NCI-H69 Homo sapiens (Human) Lung small cell carcinoma
GLC-4/ADR Homo sapiens (Human) Lung small cell carcinoma
STC 1 Homo sapiens (Human) Lung small cell carcinoma
RERF-LC-A1 Homo sapiens (Human) Lung squamous cell carcinoma
Calu-1 Homo sapiens (Human) Lung squamous cell carcinoma
HCC95 Homo sapiens (Human) Lung squamous cell carcinoma
RERF-LC-AI Tet-off Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H1650 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H1666 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H929 Homo sapiens (Human) Plasma cell myeloma
KMS-11 Homo sapiens (Human) Plasma cell myeloma
UTMC-2 Homo sapiens (Human) Plasma cell myeloma
KMS-12-PE Homo sapiens (Human) Plasma cell myeloma
NCI-H226 Homo sapiens (Human) Pleural epithelioid mesothelioma
Karpas-1106P Homo sapiens (Human) Primary mediastinal (thymic) large B-cell lymphoma